111 (Nasdaq:YI) - Stock Price, News & Analysis

YI Stock Overview

111, Inc., together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China.

About the company

YI fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	0/6
Financial Health	4/6
Dividends	0/6

Rewards

Risk Analysis

Has less than 1 year of cash runway

Volatile share price over the past 3 months

Does not have a meaningful market cap ($85M)

111, Inc. Competitors

Progressive Care

OTCPK:RXMD

US$12.0m

CLS Holdings USA

OTCPK:CLSH

US$7.6m

HealthWarehouse.com

OTCPK:HEWA

US$6.6m

Rite Aid

OTCPK:RADC.Q

US$4.0m

Price History & Performance

Summary of all time highs, changes and price drops for 111
Historical stock prices
Current Share Price	US$1.01
52 Week High	US$3.36
52 Week Low	US$0.97
Beta	0.34
1 Month Change	-2.88%
3 Month Change	-32.21%
1 Year Change	-62.17%
3 Year Change	-92.15%
5 Year Change	-87.05%
Change since IPO	-92.68%

Recent updates

111, Inc.: Undervalued After Recent Unjustified Share Price Collapse; 50% Upside

Aug 18

Is 111 (NASDAQ:YI) A Risky Investment?

Apr 09

Could The 111, Inc. (NASDAQ:YI) Ownership Structure Tell Us Something Useful?

Mar 05

Did You Miss 111's (NASDAQ:YI) 70% Share Price Gain?

Jan 29

111 (NASDAQ:YI) Has Debt But No Earnings; Should You Worry?

Dec 25

Why 111, Inc. (NASDAQ:YI) Could Be Worth Watching

Dec 04

111 reports Q3 results, provides Q4 revenue guidance

Nov 19

111, Inc.: Cheap But Risky And Controlled By Founders

Nov 16

Shareholder Returns

	YI	US Consumer Retailing	US Market
7D	1.0%	1.1%	1.0%
1Y	-62.2%	16.0%	21.9%

Price Volatility

Is YI's price volatile compared to industry and market?
YI volatility
YI Average Weekly Movement	11.0%
Consumer Retailing Industry Average Movement	4.7%
Market Average Movement	6.0%
10% most volatile stocks in US Market	16.8%
10% least volatile stocks in US Market	3.0%

Stable Share Price: YI's share price has been volatile over the past 3 months.

Volatility Over Time: YI's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

Founded	Employees	CEO	Website
2010	1,657	Junling Liu	corporate.111.com.cn

111, Inc., together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2C and B2B. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services that include online consultation services and electronic prescription services to consumers.

111, Inc. Fundamentals Summary

How do 111's earnings and revenue compare to its market cap?
YI fundamental statistics
Market cap	US$84.83m
Earnings (TTM)	-US$54.24m
Revenue (TTM)	US$2.06b

0.0x

P/S Ratio

-1.6x

P/E Ratio

Is YI overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
YI income statement (TTM)
Revenue	CN¥14.95b
Cost of Revenue	CN¥14.50b
Gross Profit	CN¥448.44m
Other Expenses	CN¥841.13m
Earnings	-CN¥392.69m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)	-4.68
Gross Margin	3.00%
Net Profit Margin	-2.63%
Debt/Equity Ratio	137.0%

How did YI perform over the long term?

See historical performance and comparison

YI Stock Overview

Rewards

Risk Analysis

111, Inc. Competitors

OTCPK:RXMD

US$12.0m

OTCPK:CLSH

US$7.6m

OTCPK:HEWA

US$6.6m

OTCPK:RADC.Q

US$4.0m

Price History & Performance

Recent News & Updates

111, Inc. to Report Q4, 2023 Results on Mar 21, 2024

Gang Yu, Junling Liu and Shanghai Guosheng Capital Management Co., Ltd. cancelled the unsolicited preliminary non-binding proposal letter to acquire 111, Inc. (NasdaqGM:YI) from Gang Yu, Junling Liu and others.

Gang Yu, Junling Liu and Shanghai Guosheng Capital Management Co., Ltd. cancelled the unsolicited preliminary non-binding proposal letter to acquire 111, Inc. (NasdaqGM:YI) from Gang Yu, Junling Liu and others.

New minor risk - Share price stability

Third quarter 2023 earnings released

111, Inc. to Report Q3, 2023 Results on Nov 30, 2023

Recent updates

111, Inc. to Report Q4, 2023 Results on Mar 21, 2024

Gang Yu, Junling Liu and Shanghai Guosheng Capital Management Co., Ltd. cancelled the unsolicited preliminary non-binding proposal letter to acquire 111, Inc. (NasdaqGM:YI) from Gang Yu, Junling Liu and others.

Gang Yu, Junling Liu and Shanghai Guosheng Capital Management Co., Ltd. cancelled the unsolicited preliminary non-binding proposal letter to acquire 111, Inc. (NasdaqGM:YI) from Gang Yu, Junling Liu and others.

New minor risk - Share price stability

Third quarter 2023 earnings released

111, Inc. to Report Q3, 2023 Results on Nov 30, 2023

Second quarter 2023 earnings released: CN¥0.68 loss per share (vs CN¥1.14 loss in 2Q 2022)

111, Inc. to Report Q2, 2023 Results on Aug 24, 2023

First quarter 2023 earnings released: CN¥0.38 loss per share (vs CN¥1.33 loss in 1Q 2022)

111, Inc. to Report Q1, 2023 Results on Jun 15, 2023

Full year 2022 earnings released: CN¥5.00 loss per share (vs CN¥8.08 loss in FY 2021)

Third quarter 2022 earnings released: CN¥1.16 loss per share (vs CN¥3.05 loss in 3Q 2021)

Insufficient new directors

111, Inc. to Report Q3, 2022 Results on Dec 01, 2022

111, Inc. Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee

Second quarter 2022 earnings released

111, Inc. Provides Revenue Guidance

111 Non-GAAP EPS of -$0.14, revenue of $453.4M

111, Inc. to Report Q2, 2022 Results on Aug 25, 2022

111, Inc.'s Inexorable Drive Towards Profitability

First quarter 2022 earnings released

Insufficient new directors

111, Inc. to Report Q1, 2022 Results on Jun 16, 2022

Full year 2021 earnings: Revenues in line with analyst expectations

111, Inc. to Report Q4, 2021 Results on Mar 17, 2022

Third quarter 2021 earnings released

Solid Earnings, Modest Buyback Fail To Boost Drug Seller 111, Inc.

111, Inc. (NasdaqGM:YI) announces an Equity Buyback for $10 million worth of its shares.

Second quarter 2021 earnings released

111, Inc. Provides Preliminary Revenue Guidance for the Third Quarter of 2021

Health Check: How Prudently Does 111 (NASDAQ:YI) Use Debt?

111, Inc.: Undervalued After Recent Unjustified Share Price Collapse; 50% Upside

First quarter 2021 earnings released: CN¥1.77 loss per share (vs CN¥1.52 loss in 1Q 2020)

111, Inc. Provides Revenue Guidance for the Second Quarter of 2021

Full year 2020 earnings released: CN¥5.54 loss per share (vs CN¥6.11 loss in FY 2019)

Is 111 (NASDAQ:YI) A Risky Investment?

Full year 2020 earnings released: CN¥5.54 loss per share (vs CN¥6.11 loss in FY 2019)

111, Inc. Provides Earnings Guidance for the First Quarter of 2021

Could The 111, Inc. (NASDAQ:YI) Ownership Structure Tell Us Something Useful?

111, Inc. to Report Q4, 2020 Results on Mar 18, 2021

111, Inc. Signs Strategic Cooperation Agreement with Jilin Baiyi Doctor Group to Create & Deliver New Models for Internet Medical Services

New 90-day high: US$12.70

Did You Miss 111's (NASDAQ:YI) 70% Share Price Gain?

New 90-day high: US$7.62

111 (NASDAQ:YI) Has Debt But No Earnings; Should You Worry?

Why 111, Inc. (NASDAQ:YI) Could Be Worth Watching

Third quarter 2020 earnings released: CN¥1.32 loss per share

111 reports Q3 results, provides Q4 revenue guidance

111, Inc.: Cheap But Risky And Controlled By Founders

New 90-day high: US$7.45

111, Inc. Announces Management Changes

111, Inc. and Shanghai Uniondrug Information Technology Join Hands to Advance Innovation in Commercial Insurance Payment

New 90-day low - US$5.96

First half earnings released

111, Inc. to Report Q2, 2020 Results on Aug 20, 2020

New 90-day low - US$6.14

Shareholder Returns

Price Volatility

About the Company